6565 Results

People

  1. Gonen
    Gonen
  2. Panageas
    Panageas
  3. Patil
    Patil
  4. Giralt
    Giralt
  5. Zhang
    Zhang
  6. Heller
    Heller
  7. Devlin
    Devlin
  8. Seshan
    Seshan
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Biostatistics Service (6565)
  2. Epidemiology and Biostatistics (6565)
  3. Department of Medicine (3849)
  4. Solid Tumor Oncology Division (2571)
  5. Survivorship Research (2488)
  6. Surgery (2392)
  7. Population Sciences Research Program (2339)
  8. Center for Pancreatic Cancer Research (2080)
  9. GSK Faculty (1978)
  10. Department of Pathology and Laboratory Medicine (1573)
  1. "Biostatistics Service"
Formats
  1. Journal Article (3978)
  2. Meeting Abstract (2395)
  3. Research Letter (51)
  4. Conference Paper (37)
  5. Correspondence (26)
  6. Editorial (25)
  7. Review (21)
  8. Miscellaneous (14)
  9. Book Section (13)
  10. Book Whole (3)
  11. Guidelines (2)
Groups
  1. Biostatistics Service (6565)
  2. Epidemiology and Biostatistics (6565)
  3. Department of Medicine (3849)
  4. Solid Tumor Oncology Division (2571)
  5. Survivorship Research (2488)
  6. Surgery (2392)

More Groups

People
  1. Mithat Gonen (1028)
  2. Sean Devlin (601)
  3. Katherine Panageas (512)
  4. Sujata Patil (511)
  5. Sergio Giralt (465)
  6. Zhigang Zhang (427)

More People

Years
  1. 2025 (119)
  2. 2024 (362)
  3. 2023 (411)
  4. 2022 (407)
  5. 2021 (369)
  6. 2020 (394)

More Years

Publications
  1. Journal of Clinical Oncology (1058)
  2. Blood (432)
  3. Annals of Surgical Oncology (308)
  4. International Journal of Radiation Oncology, Biology, Physics (233)
  5. Clinical Cancer Research (195)
  6. Biology of Blood and Marrow Transplantation (174)

More Publications

Publishers
  1. American Society of Clinical Oncology (1124)
  2. Elsevier Inc. (930)
  3. Springer (625)
  4. American Society of Hematology (486)
  5. American Association for Cancer Research (430)
  6. Nature Publishing Group (311)

More Publishers

Results (6565)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor epidermal growth factor receptor (EGFR) mutations
    Meeting Abstract

    Janjigian, Y. Y.; Park, B. J.; Kris, M. G.; Miller, V. A.; Riely, G. J.; Zheng, J.; Dycoco, J. P.; Shen, R.; Azzoli, C. G.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Determinants of outcome in elderly patients with positive sentinel lymph nodes
    Meeting Abstract

    Gemignani, M.; Karam, A.; Hsu, M.; Patil, S.; Stempel, M.; Traina, T.; Ho, A.; Cody, H. 3rd; Morrow, M.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Operative outcomes using bevacizumab, docetaxel, and cisplatin as induction therapy in patients with operable lung cancer
    Meeting Abstract

    Finley, D. J.; Shen, R.; Rizvi, N. A.; Rusch, V. W.; Kris, M. G.; on behalf of the MSKCC Thoracic Disease Management Team
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I study of everolimus (E; RAD001) + low-dose weekly cisplatin (C) for patients with advanced solid tumors: Preliminary results
    Meeting Abstract

    Fury, M. G.; Sherman, E.; Stambuk, H.; Haque, S.; Lisa, D.; Shen, R.; Carlson, D.; Pfister, D. G.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Paclitaxel (T) plus ifosfamide (I) followed by high-dose carboplatin (C) and etoposide (E) with autologous stem cell support for patients (pts) with previously treated germ cell tumors (GCT): TI-CE results and prognostic factor analysis in 107 pts
    Meeting Abstract

    Feldman, D. R.; Sheinfeld, J.; Bajorin, D. F.; Fischer, P.; Turkula, S.; Ishill, N.; Patil, S.; Bains, M.; Bosl, G. J.; Motzer, R. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Diabetes mellitus (DM), serum glucose, and outcome in gastroesophageal (GE) cancer
    Meeting Abstract

    Feilchenfeldt, J. W.; Capanu, M.; Farooki, A.; Sully, D.; Miron, B.; Power, D. G.; Jhawer, M.; Ilson, D. H.; Kelsen, D. P.; Shah, M. A.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Dose-dense (DD) cyclophosphamide, methotrexate, and fluorouracil (CMF) at 14-day intervals: A pilot study of every 14- and 10-11-day dosing intervals for women with early-stage breast cancer
    Meeting Abstract

    Drullinsky, P.; Fornier, M. N.; Sugarman, S.; D'Andrea, G.; Troso-Sandoval, T.; Seidman, A. D.; Yuan, J.; Patil, S.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Evaluation of the correlation of baseline blood pressure (BP) and plasma renin activity (PRA) with bevacizumab (B)-mediated hypertension in patients with early-stage breast cancer
    Meeting Abstract

    Dickler, M. N.; McArthur, H. L.; Nulsen, B.; Patil, S.; Sealey, J.; Laragh, J.; Merali, C.; Steingart, R.; Hudis, C.; Rugo, H.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Employment status among low-income Caucasian and Latina breast cancer survivors
    Meeting Abstract

    Blinder, V. S.; Patil, S.; Diamant, A.; Thind, A.; Maly, R.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment
    Meeting Abstract

    Poultsides, G. A.; Servais, E. L.; Saltz, L. B.; Patil, S.; Kemeny, N. E.; Guillem, J. G.; Weiser, M.; Temple, L. K.; Wong, W.; Paty, P. B.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save